Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Ambient air pollution, covert cerebrovascular disease and cognition: results from the ISSYS study

  • Ballvé, Alejandro
  • Pizarro Gonzálvez, Jesús
  • Maisterra Santos, Olga
  • Riba Llena, Yolanda
  • Pujadas, Francesc
  • Jimenez-Balado, Joan
  • Palasi Franco, Antonio
  • Delgado Martínez, María Pilar
Air pollution; Cerebrovascular disorders; Cognitive impairment, Contaminación del aire; Trastornos cerebrovasculares; Deterioro cognitivo, Contaminació de l'aire; Trastorns cerebrovasculars; Deteriorament cognitiu, Background and purpose Although air pollution (AP) has been associated with stroke and dementia, data regarding its relationship with covert cerebrovascular disease (cCVD) and cognition over time are sparse. The aim of this study was to explore these relationships. Methods A prospective population-based study of 976 stroke-free and non-demented individuals living in Barcelona, Spain, was conducted during 2010–2016. A land use regression model was used to estimate the exposure of each participant to AP: NOx, NO2, PM2.5, PM10, PMcoarse and PM2.5 absorbance. Cognitive function and cCVD were assessed at baseline (n = 976) and 4 years after (n = 317). Multivariate-adjusted models were developed. Results At baseline, 99 participants (10.1%) had covert brain infarcts and 91 (9.3%) had extensive periventricular white matter hyperintensities (WMHs). Marked subcortical WMH progression was seen in 19.7%; the incidence of other covert cerebrovascular lessons ranged between 5% and 6% each. PM2.5 was related to higher odds of having a covert brain infarct (odds ratio [OR] 2.21; 95% confidence interval [CI] 1.06–4.60). PM2.5 absorbance was related to higher odds of having extensive subcortical WMHs (OR 1.72; 95% CI 1.13–2.60), whereas NO2 was related to higher odds of having extensive subcortical (OR 1.66; 95% CI 1.17–2.35) or periventricular (OR 1.96; 95% CI 1.10–3.50) WMHs and to higher odds of developing marked subcortical WMH progression (OR 1.40; 95% CI 1.05–1.90). NOx was related to incident cerebral microbleeds (OR 1.36; 95% CI 1.04–1.79). There was no association between AP and cognition. Conclusions Air pollutant predicts the presence and accumulation of cCVD. Its impact on cognitive impairment remains to be determined., This work was supported by the Instituto de Salud Carlos III (grant numbers PI14/1535, PI19/00217, INT20/00084, CM20/00218 and CM22/00226) co-financed by the European Regional Development Fund. The Neurovascular Research Laboratory receives funds from the Spanish Research Stroke Network (RD/16/0019/0021 and RICORS-ICTUS-Enfermedades Vasculares Cerebrales, RD21/0006/0007). MCT is funded by a Ramón y Cajal Fellowship (RYC-2017-01892) from the Spanish Ministry of Science, Innovation and Universities and co-funded by the European Social Fund. ISGlobal acknowledges support from the Spanish Ministry of Science and Innovation through the ‘Centro de Excelencia Severo Ochoa 2019–2023’ Programme (CEX2018-000806-S) and support from the Generalitat de Catalunya through the CERCA Programme.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

New candidate blood biomarkers potentially associated with white matter hyperintensities progression

  • Jimenez Balado, Joan
  • Pizarro Gonzálvez, Jesús
  • Riba Llena, Yolanda
  • Penalba Morenilla, Anna
  • Faura Llorens, Julia
  • Pala Vila, Elena
  • Montaner Villalonga, Joan
  • Hernandez Guillamon, Maria Mar
  • Delgado Martínez, Maria Pilar
Barrera hematoencefàlica; Interaccions neurovasculars; Neurociència, Barrera hematoencefálica; Interacciones neurovasculares; Neurociencia, Blood-brain barrier; Neuro-vascular interactions; Neuroscience, We aimed to discover blood biomarkers associated with longitudinal changes in white matter hyperintensities (WMH). This study was divided into a discovery phase and a replication phase. Subjects in both studies were patients with hypertension, aged 50-70, who underwent two magnetic resonance imaging (MRI) sessions and blood extractions over a 4-year follow-up period. In the discovery phase, we screened 1305 proteins in 12 subjects with WMH progression and in 12 matched control subjects. We found that 41 proteins were differentially expressed: 13 were upregulated and 28 were downregulated. We subsequently selected three biomarkers for replication in baseline and follow-up samples in 80 subjects with WMH progression and in 80 control subjects. The selected protein candidates for the replication were MMP9 (matrix metalloproteinase-9), which was higher in cases, MET (hepatocyte growth factor receptor) and ASAH2 (neutral ceramidase), which were both lower in cases of WMH progression. Baseline biomarker concentrations did not predict WMH progression. In contrast, patients with WMH progression presented a steeper decline in MET over time. Furthermore, cases showed higher MMP9 and lower ASAH2 levels than controls at the follow-up. These results indicate that MMP9, MET, and ASAH2 are potentially associated with the progression of WMH, and could therefore be interesting candidates to validate in future studies., Funds were obtained from the Instituto de Salud Carlos III (Grant Numbers: PI14/01535, PI17/02222, ICI14/307, PI19/00217, CP15/00010, and JR15/00032), incorporation of scientists and technicians to research groups (PERIS, SLT006/17/00266) and the AGAUR (FI_DGR 2017, Grant Number 2017_FI_B 00064), with the support of the Secretary of Universities and Research (Department of Economy and Knowledge, Generalitat de Catalunya), and was cofinanced by the European Regional Development Fund. The neurovascular research laboratory receives funds from the Spanish research stroke network (RD/16/0019/0021).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Diabetes, Albuminuria and the Kidney-Brain Axis

  • Ariton, Diana Maria
  • Jimenez Balado, Joan
  • Maisterra Santos, Olga
  • Pujadas Navinés, Francesc
  • Soler Romeo, Maria Jose
  • Delgado Martínez, Maria Pilar
Malaltia renal crònica; Demència; Diabetis, Enfermedad renal cronica; Demencia; Diabetes, Chronic kidney disease; Dementia; Diabetes, Cognitive decline and kidney disease are significant public health problems that share similar characteristics and risk factors. The pathophysiology of the kidney–brain axis is not completely understood, and studies analysing the relationship between the biomarkers of kidney damage and cognitive impairment show different results. This article focuses on the epidemiological and clinical aspects concerning the association of albuminuria, a marker for endothelial dysfunction and microvascular disease, and cognitive impairment in patients with chronic kidney disease, diabetic kidney disease and end-stage kidney disease. Most studies show a positive relationship between albuminuria and cognitive impairment in all groups, but evidence in type 2 diabetes (T2D) patients is limited. We briefly discuss the mechanisms underlying these associations, such as damage to the microvascular circulation, leading to hypoperfusion and blood pressure fluctuations, as well as increased inflammation and oxidative stress, both in the brain and in the kidneys. Further clinical and epidemiological studies developed to understand the interplay between the kidneys and brain diseases will hopefully lead to a reduction in cognitive impairment in these patients., This research was funded by the Instituto de Salud Carlos III (Grant Nos. PI17/02222 and PI19/00217) and co-financed by the European Regional Development Fund FEDER.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Diabetes, Albuminuria and the Kidney-Brain Axis

  • Ariton, Diana María|||0000-0002-6035-5466
  • Jiménez-Balado, Joan|||0000-0003-4125-9134
  • Maisterra Santos, Olga
  • Pujadas, Francesc|||0000-0003-3569-2601
  • Soler, María José|||0000-0003-3621-0766
  • Delgado Martínez, María Pilar|||0000-0002-1628-4488
Cognitive decline and kidney disease are significant public health problems that share similar characteristics and risk factors. The pathophysiology of the kidney-brain axis is not completely understood, and studies analysing the relationship between the biomarkers of kidney damage and cognitive impairment show different results. This article focuses on the epidemiological and clinical aspects concerning the association of albuminuria, a marker for endothelial dysfunction and microvascular disease, and cognitive impairment in patients with chronic kidney disease, diabetic kidney disease and end-stage kidney disease. Most studies show a positive relationship between albuminuria and cognitive impairment in all groups, but evidence in type 2 diabetes (T2D) patients is limited. We briefly discuss the mechanisms underlying these associations, such as damage to the microvascular circulation, leading to hypoperfusion and blood pressure fluctuations, as well as increased inflammation and oxidative stress, both in the brain and in the kidneys. Further clinical and epidemiological studies developed to understand the interplay between the kidneys and brain diseases will hopefully lead to a reduction in cognitive impairment in these patients.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

New candidate blood biomarkers potentially associated with white matter hyperintensities progression

  • Jiménez-Balado, Joan|||0000-0003-4125-9134
  • Pizarro Gonzálvez, Jesús|||0000-0002-5808-9293
  • Riba Llena, Iolanda
  • Penalba, Anna
  • Faura, Júlia|||0000-0002-8436-1377
  • Palà, Elena|||0000-0002-1074-990X
  • Montaner, Joan|||0000-0003-4845-2279
  • Hernandez Guillamon, Maria Mar|||0000-0001-8844-0091
  • Delgado Martínez, María Pilar|||0000-0002-1628-4488
We aimed to discover blood biomarkers associated with longitudinal changes in white matter hyperintensities (WMH). This study was divided into a discovery phase and a replication phase. Subjects in both studies were patients with hypertension, aged 50-70, who underwent two magnetic resonance imaging (MRI) sessions and blood extractions over a 4-year follow-up period. In the discovery phase, we screened 1305 proteins in 12 subjects with WMH progression and in 12 matched control subjects. We found that 41 proteins were differentially expressed: 13 were upregulated and 28 were downregulated. We subsequently selected three biomarkers for replication in baseline and follow-up samples in 80 subjects with WMH progression and in 80 control subjects. The selected protein candidates for the replication were MMP9 (matrix metalloproteinase-9), which was higher in cases, MET (hepatocyte growth factor receptor) and ASAH2 (neutral ceramidase), which were both lower in cases of WMH progression. Baseline biomarker concentrations did not predict WMH progression. In contrast, patients with WMH progression presented a steeper decline in MET over time. Furthermore, cases showed higher MMP9 and lower ASAH2 levels than controls at the follow-up. These results indicate that MMP9, MET, and ASAH2 are potentially associated with the progression of WMH, and could therefore be interesting candidates to validate in future studies.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

New candidate blood biomarkers potentially associated with white matter hyperintensities progression

  • Jimenez Balado, Joan
  • Pizarro Gonzálvez, Jesús
  • Riba Llena, Yolanda
  • Penalba Morenilla, Anna
  • Faura Llorens, Julia
  • Pala Vila, Elena
  • Montaner Villalonga, Joan
  • Hernandez Guillamon, Maria Mar
  • Delgado Martínez, Maria Pilar
Barrera hematoencefàlica; Interaccions neurovasculars; Neurociència, Barrera hematoencefálica; Interacciones neurovasculares; Neurociencia, Blood-brain barrier; Neuro-vascular interactions; Neuroscience, We aimed to discover blood biomarkers associated with longitudinal changes in white matter hyperintensities (WMH). This study was divided into a discovery phase and a replication phase. Subjects in both studies were patients with hypertension, aged 50-70, who underwent two magnetic resonance imaging (MRI) sessions and blood extractions over a 4-year follow-up period. In the discovery phase, we screened 1305 proteins in 12 subjects with WMH progression and in 12 matched control subjects. We found that 41 proteins were differentially expressed: 13 were upregulated and 28 were downregulated. We subsequently selected three biomarkers for replication in baseline and follow-up samples in 80 subjects with WMH progression and in 80 control subjects. The selected protein candidates for the replication were MMP9 (matrix metalloproteinase-9), which was higher in cases, MET (hepatocyte growth factor receptor) and ASAH2 (neutral ceramidase), which were both lower in cases of WMH progression. Baseline biomarker concentrations did not predict WMH progression. In contrast, patients with WMH progression presented a steeper decline in MET over time. Furthermore, cases showed higher MMP9 and lower ASAH2 levels than controls at the follow-up. These results indicate that MMP9, MET, and ASAH2 are potentially associated with the progression of WMH, and could therefore be interesting candidates to validate in future studies., Funds were obtained from the Instituto de Salud Carlos III (Grant Numbers: PI14/01535, PI17/02222, ICI14/307, PI19/00217, CP15/00010, and JR15/00032), incorporation of scientists and technicians to research groups (PERIS, SLT006/17/00266) and the AGAUR (FI_DGR 2017, Grant Number 2017_FI_B 00064), with the support of the Secretary of Universities and Research (Department of Economy and Knowledge, Generalitat de Catalunya), and was cofinanced by the European Regional Development Fund. The neurovascular research laboratory receives funds from the Spanish research stroke network (RD/16/0019/0021).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Ambient air pollution, covert cerebrovascular disease and cognition: results from the ISSYS study

  • Ballvé, Alejandro
  • Pizarro Gonzálvez, Jesús
  • Maisterra Santos, Olga
  • Riba Llena, Yolanda
  • Pujadas, Francesc
  • Jimenez-Balado, Joan
  • Palasi Franco, Antonio
  • Delgado Martínez, María Pilar
Air pollution; Cerebrovascular disorders; Cognitive impairment, Contaminación del aire; Trastornos cerebrovasculares; Deterioro cognitivo, Contaminació de l'aire; Trastorns cerebrovasculars; Deteriorament cognitiu, Background and purpose Although air pollution (AP) has been associated with stroke and dementia, data regarding its relationship with covert cerebrovascular disease (cCVD) and cognition over time are sparse. The aim of this study was to explore these relationships. Methods A prospective population-based study of 976 stroke-free and non-demented individuals living in Barcelona, Spain, was conducted during 2010–2016. A land use regression model was used to estimate the exposure of each participant to AP: NOx, NO2, PM2.5, PM10, PMcoarse and PM2.5 absorbance. Cognitive function and cCVD were assessed at baseline (n = 976) and 4 years after (n = 317). Multivariate-adjusted models were developed. Results At baseline, 99 participants (10.1%) had covert brain infarcts and 91 (9.3%) had extensive periventricular white matter hyperintensities (WMHs). Marked subcortical WMH progression was seen in 19.7%; the incidence of other covert cerebrovascular lessons ranged between 5% and 6% each. PM2.5 was related to higher odds of having a covert brain infarct (odds ratio [OR] 2.21; 95% confidence interval [CI] 1.06–4.60). PM2.5 absorbance was related to higher odds of having extensive subcortical WMHs (OR 1.72; 95% CI 1.13–2.60), whereas NO2 was related to higher odds of having extensive subcortical (OR 1.66; 95% CI 1.17–2.35) or periventricular (OR 1.96; 95% CI 1.10–3.50) WMHs and to higher odds of developing marked subcortical WMH progression (OR 1.40; 95% CI 1.05–1.90). NOx was related to incident cerebral microbleeds (OR 1.36; 95% CI 1.04–1.79). There was no association between AP and cognition. Conclusions Air pollutant predicts the presence and accumulation of cCVD. Its impact on cognitive impairment remains to be determined., This work was supported by the Instituto de Salud Carlos III (grant numbers PI14/1535, PI19/00217, INT20/00084, CM20/00218 and CM22/00226) co-financed by the European Regional Development Fund. The Neurovascular Research Laboratory receives funds from the Spanish Research Stroke Network (RD/16/0019/0021 and RICORS-ICTUS-Enfermedades Vasculares Cerebrales, RD21/0006/0007). MCT is funded by a Ramón y Cajal Fellowship (RYC-2017-01892) from the Spanish Ministry of Science, Innovation and Universities and co-funded by the European Social Fund. ISGlobal acknowledges support from the Spanish Ministry of Science and Innovation through the ‘Centro de Excelencia Severo Ochoa 2019–2023’ Programme (CEX2018-000806-S) and support from the Generalitat de Catalunya through the CERCA Programme.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Diabetes, Albuminuria and the Kidney-Brain Axis

  • Ariton, Diana Maria
  • Jimenez Balado, Joan
  • Maisterra Santos, Olga
  • Pujadas Navinés, Francesc
  • Soler Romeo, Maria Jose
  • Delgado Martínez, Maria Pilar
Malaltia renal crònica; Demència; Diabetis, Enfermedad renal cronica; Demencia; Diabetes, Chronic kidney disease; Dementia; Diabetes, Cognitive decline and kidney disease are significant public health problems that share similar characteristics and risk factors. The pathophysiology of the kidney–brain axis is not completely understood, and studies analysing the relationship between the biomarkers of kidney damage and cognitive impairment show different results. This article focuses on the epidemiological and clinical aspects concerning the association of albuminuria, a marker for endothelial dysfunction and microvascular disease, and cognitive impairment in patients with chronic kidney disease, diabetic kidney disease and end-stage kidney disease. Most studies show a positive relationship between albuminuria and cognitive impairment in all groups, but evidence in type 2 diabetes (T2D) patients is limited. We briefly discuss the mechanisms underlying these associations, such as damage to the microvascular circulation, leading to hypoperfusion and blood pressure fluctuations, as well as increased inflammation and oxidative stress, both in the brain and in the kidneys. Further clinical and epidemiological studies developed to understand the interplay between the kidneys and brain diseases will hopefully lead to a reduction in cognitive impairment in these patients., This research was funded by the Instituto de Salud Carlos III (Grant Nos. PI17/02222 and PI19/00217) and co-financed by the European Regional Development Fund FEDER.